3i Nanotech develops point-of-care platform technology to track protein biomarkers in human samples.
3i Nanotech develops point-of-care platform technology to track protein biomarkers in human samples. The company was founded in 2018 and is based in Greensboro, North Carolina.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 24, 2019 | Grant | $224.49K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |